Skip to content

Nuvectis Pharma

US · NVCT #3557 by market cap Listed 2022
19.39 -0.45 -2.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 19.57 -1.36%
After-hours 19.39 0.00%
28.539.3119.392026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on NVCT?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +106.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 7.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -4.20%
1M -5.83%
3M -16.96%
6M +82.41%
YTD +156.82%
1Y +229.76%
3Y +133.90%

Key statistics

Price & volume

Prev close
19.84
Open
19.60
Day range
19.02 - 20.18
Avg price
19.36
Volume
301.61K
Turnover
5.84M
Amplitude
5.85%
52-week range
5.77 - 29.28

Valuation

P/E
-14.69
P/E (TTM)
-9.70
P/B
5.26
EPS
-1.32
Net profit
-45.39M
Net assets
126.65M

Share structure

Market cap
666.80M
Float cap
446.17M
Shares out
34.39M
Float shares
23.01M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2022-02-04
52-week range 58% of range
5.77 29.28

33.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-246.23K net over the window

Short interest

Shares short
2.54M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Nuvectis Pharma (NVCT)?

Nuvectis Pharma last traded at 19.39. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Nuvectis Pharma's market cap?

About 666.80M.

What is the P/E ratio of Nuvectis Pharma?

The trailing twelve-month P/E is -9.70. The Valuation tab shows it against the stock's own five-year range.

Does Nuvectis Pharma pay a dividend?

Nuvectis Pharma does not currently pay a regular dividend.

Is Nuvectis Pharma a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 34.50, which implies 77.9% upside from the current price. This is not investment advice.

What is Nuvectis Pharma's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Nuvectis Pharma a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Nuvectis Pharma discussion 0 comments

Add a comment